|
Box | Folder
|
Title
|
|
Presentations on 35mm Slides,
1961-2005 [subseries]:
|
19 |
34 |
Influenza Dearborn TS1[E],
undated
|
19 |
35 |
Influenza TS1,
undated
|
19 |
36-40 |
Mycoplasma,
undated
|
20 |
1-2 |
PI Mpn epidem.,
undated
|
20 |
3 |
Poly IC study Knopp,
undated
|
20 |
4 |
Respiratory Syncitial,
undated
|
20 |
5 |
Respiratory Syncitial Coates,
undated
|
20 |
6 |
Smith and Chanock Eaton vol,
undated
|
20 |
7 |
Mycoplasma,
1961
|
20 |
8 |
Pneumonia,
1961
|
20 |
9 |
Respiratory Syncytial Mpn,
1961
|
20 |
10 |
Adeno caps PI,
1964
|
20 |
11-12 |
Mycoplasma,
c.1965
|
20 |
13 |
Respiratory Syncytial and Para,
c.1966
|
20 |
14 |
IOM priorities and Respiratory Syncytial Virus,
1966
|
20 |
15 |
Mycoplasma,
c.1967
|
20 |
16 |
Mycoplasma Boston,
1967
|
20 |
17 |
Importance viruses and Mpn respiratory disease,
1968
|
20 |
18 |
Respiratory Syncytial temperature sensitive,
1968
|
20 |
19 |
Mycoplasma,
1969
|
20 |
20 |
Mycoplasma pneumoniae ASM,
1970
|
20 |
21 |
Mycoplasma, pneumonia, pap,
1970
|
20 |
22 |
PAHO,
December 1970
|
20 |
23 |
Flu (temperature sensitive),
1971
|
20 |
24 |
Mycoplasma,
1971
|
20 |
25 |
Respiratory Syncytial Virus,
1971
|
20 |
26 |
Mycoplasma NY Acad.,
January 1973
|
20 |
27 |
Respiratory Syncytial,
1973
|
20 |
28 |
Animal rights,
c.1979
|
20 |
29 |
Rotavirus, dengue, vaccines, etc.,
1980-1981
|
20 |
30 |
Long-term goals and strategy of LID research / Sabin polio vaccine,
1986-1988
|
20 |
31 |
RSV, dengue, etc.,
c.1989
|
20 |
32 |
Respiratory Syncytial,
1989
|
20 |
33 |
Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries,
1990
|
20 |
34 |
Respiratory Syncytial Virus vaccines,
1990
|
20 |
35 |
Rotavirus,
1990
|
20 |
36 |
Respiratory Syncytial Virus mabs and fabs,
1990-1995
|
20 |
37 |
Respiratory Syncytial Virus,
1991
|
20 |
38 |
Respiratory Syncytial Virus,
1992-1993
|
20 |
39 |
Respiratory Syncytial Virus (cont'd),
1992-1993
|
20 |
40 |
St. Lucia - history of respiratory,
December 2000
|
20 |
41 |
Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens,
2004
|
20 |
42 |
Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development,
2005
|
|